Russia’s RDIF Says Agreement Reached to Produce 100Mln Doses of Sputnik V Vaccine in China

Apr 1, 2021 | EARNINGS

MOSCOW (Sputnik) – The Russian Direct Investment Fund (RDIF) announced on Thursday that it agreed with China’s TopRidge Pharma pharmaceutical company to produce over 100 million doses of Russia’s Sputnik V coronavirus vaccine annually in China.

Read More

Pin It on Pinterest